NASDAQ:AQBAquabounty Technologies Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Aquabounty Technologies Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $3.86 -0.50 (-11.47 %) (As of 07/15/2020 04:00 PM ET) Add Compare Share Today's Range$3.65Now: $3.86▼$4.5550-Day Range$2.32MA: $2.98▼$3.8852-Week Range$1.52Now: $3.86▼$4.55Volume513,200 shsAverage Volume219,798 shsMarket Capitalization$123.87 millionP/E RatioN/ADividend YieldN/ABeta1.13 ProfileAnalyst RatingsAdvanced ChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media AquaBounty Technologies, Inc., a biotechnology company, develops and markets products to enhance productivity in aquaculture. It offers AquAdvantage Salmon, a genetically modified Atlantic salmon for human consumption. The company was formerly known as Aqua Bounty Farms, Inc. and changed its name to AquaBounty Technologies, Inc. in June 2004. AquaBounty Technologies, Inc. was founded in 1991 and is headquartered in Maynard, Massachusetts. AquaBounty Technologies, Inc. is a subsidiary of Intrexon Corporation.Read More Beat the Market (BTM) Rank™ 2.5 Analyst's Opinion Consensus RatingAquabounty Technologies has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $4.50, Aquabounty Technologies has a potential upside of 16.6% from its current price of $3.86.Amount of Analyst CoverageAquabounty Technologies has only been the subject of 2 research reports in the past 90 days. Previous Next 2.5 Community Rank Outperform VotesAquabounty Technologies has received 173 “outperform” votes. (Add your “outperform” vote.)Underperform VotesAquabounty Technologies has received 179 “underperform” votes. (Add your “underperform” vote.)Community SentimentAquabounty Technologies has received 50.85% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Aquabounty Technologies and other stocks. Vote “Outperform” if you believe AQB will outperform the S&P 500 over the long term. Vote “Underperform” if you believe AQB will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldAquabounty Technologies does not currently pay a dividend.Dividend GrowthAquabounty Technologies does not have a long track record of dividend growth. Previous Next 1.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Aquabounty Technologies insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 2.50% of the stock of Aquabounty Technologies is held by insiders.Percentage Held by Institutions60.40% of the stock of Aquabounty Technologies is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Aquabounty Technologies are expected to grow in the coming year, from ($0.37) to ($0.25) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Aquabounty Technologies is -6.43, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Aquabounty Technologies is -6.43, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAquabounty Technologies has a P/B Ratio of 3.51. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 2.5Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.33 out of 5 stars Industry, Sector and Symbol Stock Exchange NASDAQ Industry Fishing, hunting & trapping Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:AQB Previous Symbol CUSIPN/A CIK1603978 Webwww.aquabounty.com Phone978-648-6000Debt Debt-to-Equity Ratio0.12 Current Ratio8.32 Quick Ratio7.42Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$190,000.00 Price / Sales651.93 Cash FlowN/A Price / Cash FlowN/A Book Value$1.10 per share Price / Book3.51Profitability EPS (Most Recent Fiscal Year)($0.66) Net Income$-13,230,000.00 Net MarginsN/A Return on Equity-47.07% Return on Assets-38.40%Miscellaneous Employees39 Outstanding Shares32,090,000Market Cap$123.87 million Next Earnings Date8/4/2020 (Estimated) OptionableNot Optionable NASDAQ:AQB Rates by TradingView Receive AQB News and Ratings via Email Sign-up to receive the latest news and ratings for AQB and its competitors with MarketBeat's FREE daily newsletter. Aquabounty Technologies (NASDAQ:AQB) Frequently Asked Questions How has Aquabounty Technologies' stock been impacted by COVID-19 (Coronavirus)? Aquabounty Technologies' stock was trading at $1.85 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, AQB stock has increased by 108.6% and is now trading at $3.86. View which stocks have been most impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of Aquabounty Technologies? 3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aquabounty Technologies in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Aquabounty Technologies. When is Aquabounty Technologies' next earnings date? Aquabounty Technologies is scheduled to release its next quarterly earnings announcement on Tuesday, August 4th 2020. View our earnings forecast for Aquabounty Technologies. How were Aquabounty Technologies' earnings last quarter? Aquabounty Technologies Inc (NASDAQ:AQB) released its earnings results on Tuesday, May, 5th. The company reported ($0.11) EPS for the quarter, beating the Thomson Reuters' consensus estimate of ($0.13) by $0.02. The firm earned $0.01 million during the quarter, compared to analysts' expectations of $0.01 million. View Aquabounty Technologies' earnings history. What price target have analysts set for AQB? 3 equities research analysts have issued 1 year price targets for Aquabounty Technologies' shares. Their forecasts range from $3.50 to $5.00. On average, they expect Aquabounty Technologies' stock price to reach $4.50 in the next year. This suggests a possible upside of 16.6% from the stock's current price. View analysts' price targets for Aquabounty Technologies. What are Wall Street analysts saying about Aquabounty Technologies stock? Here are some recent quotes from research analysts about Aquabounty Technologies stock: 1. According to Zacks Investment Research, "AquaBounty Technologies, Inc. is a biotechnology company. It focused on enhancing productivity in aquaculture. The company operates primarily in Maynard, Massachusetts and Fortune, Prince Edward Island. AquaBounty Technologies, Inc. is based in Maynard, United States. " (1/14/2020) 2. National Securities analysts commented, " Second Quarter Results. An operating loss of $4.0 million fell below our estimated loss of $2.8 million, driven largely by sequential increases in G&A from $2.0 million in the first quarter to $3.1 million in the second quarter. We believe some of the increases were one time in nature, although we believe our prior OpEx estimates in advance of commercialization were too light. Production Schedule On Track. With AquAdvantage Salmon (AAS) in the Indiana and Rollo Bay grow out facilities, we continue to expect initial harvests by the end of 2020. A one-time harvest of conventional salmon is also expected in the third quarter of 2020. We look for a regular introduction of AAS into the grow out phase which should enable year-round harvest. What Is Next? With production now underway in both facilities, we believe management is focused on securing buyers for the initial harvest and making preliminary estimates on future expansion. The commercial team is being developed, highlighted by the introduction of CCO David Melbourne Jr in the quarter. We believe expansion plans will be formally announced as commercial revenues are realized and will initially be an expansion of the current Indiana facility. Initial AAS Buyer The Next Major Catalyst. We believe a formal announcement of the first buyers of AAS will represent a significant catalyst for the stock. With the first harvest of AAS anticipated in the third quarter of 2020, we expect buyers to commit around the Spring of 2020. We expect investors on the sideline are awaiting this announcement, and thus believe as buyers are secured and visibility of revenue is enhanced that shares will make a meaningful and sustainable movement upward." (8/7/2019) Has Aquabounty Technologies been receiving favorable news coverage? Media stories about AQB stock have trended negative on Thursday, InfoTrie reports. The research firm identifies positive and negative press coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Aquabounty Technologies earned a media sentiment score of -2.9 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 1.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View the latest news about Aquabounty Technologies. Are investors shorting Aquabounty Technologies? Aquabounty Technologies saw a drop in short interest during the month of June. As of June 30th, there was short interest totaling 180,300 shares, a drop of 7.2% from the June 15th total of 194,200 shares. Based on an average daily volume of 110,200 shares, the short-interest ratio is presently 1.6 days. Approximately 1.4% of the shares of the company are sold short. View Aquabounty Technologies' Current Options Chain. Who are some of Aquabounty Technologies' key competitors? Some companies that are related to Aquabounty Technologies include Satsuma Pharmaceuticals (STSA), Personalis (PSNL), Extendicare (EXE), BioSpecifics Technologies (BSTC), Prevail Therapeutics (PRVL), AC Immune (ACIU), Owens & Minor (OMI), DBV TECHNOLOGIE/S (DBVT), Rubius Therapeutics (RUBY), Mirum Pharmaceuticals (MIRM), Paradigm Biopharmaceuticals (PAR), Emisphere Technologies (EMIS), Advanced Medical Solutions Group (AMS), AxoGen (AXGN) and Brookdale Senior Living (BKD). View all competitors. What other stocks do shareholders of Aquabounty Technologies own? Based on aggregate information from My MarketBeat watchlists, some companies that other Aquabounty Technologies investors own include Celldex Therapeutics (CLDX), Precigen (PGEN), Aurora Cannabis (ACB), NovaBay Pharmaceuticals (NBY), Ocular Therapeutix (OCUL), Rigel Pharmaceuticals (RIGL), Vistagen Therapeutics (VTGN), ZIOPHARM Oncology (ZIOP), Adaptimmune Therapeutics (ADAP) and Adamis Pharmaceuticals (ADMP). Who are Aquabounty Technologies' key executives? Aquabounty Technologies' management team includes the following people: Mr. David A. Frank, CFO & Treasurer (Age 59)Dr. Ronald L. Stotish, Exec. Director & Chief Technology Officer (Age 70)Mr. Alejandro Rojas, Chief Operating Officer of Aquabounty Farms (Age 57)Ms. Sylvia Wulf, CEO, Pres & Exec. Director (Age 61)Mr. Christopher H. Martin, Gen. Counsel & Company Sec. (Age 53) What is Aquabounty Technologies' stock symbol? Aquabounty Technologies trades on the NASDAQ under the ticker symbol "AQB." How do I buy shares of Aquabounty Technologies? Shares of AQB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Aquabounty Technologies' stock price today? One share of AQB stock can currently be purchased for approximately $3.86. How big of a company is Aquabounty Technologies? Aquabounty Technologies has a market capitalization of $123.87 million and generates $190,000.00 in revenue each year. The company earns $-13,230,000.00 in net income (profit) each year or ($0.66) on an earnings per share basis. Aquabounty Technologies employs 39 workers across the globe. What is Aquabounty Technologies' official website? The official website for Aquabounty Technologies is www.aquabounty.com. How can I contact Aquabounty Technologies? Aquabounty Technologies' mailing address is 2 MILL & MAIN PLACE SUITE 395, MAYNARD MA, 01754. The company can be reached via phone at 978-648-6000 or via email at [email protected] This page was last updated on 7/16/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
